Insider Sell: Celldex Therapeutics
4:23PM ET 8/17/2022 MT NewswiresRichard M. Wright, Senior Vice President and Chief Commercial Officer, on August 15, 2022, sold 15,328 shares in Celldex Therapeutics (CLDX) for $578,048....
Richard M. Wright, Senior Vice President and Chief Commercial Officer, on August 15, 2022, sold 15,328 shares in Celldex Therapeutics (CLDX) for $578,048....
Anthony S Marucci, Director, President and CEO, on August 15, 2022, sold 120,000 shares in Celldex Therapeutics (CLDX) for $4,519,572. Following the Form 4...
Samuel Bates Martin, Senior Vice President and Chief Financial Officer, on August 11, 2022, sold 20,000 shares in Celldex Therapeutics (CLDX) for $730,485....
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Address | Perryville III Building Hampton, New Jersey 08827 |
Phone | +1.908.200.7500 |
Number of Employees | 137 |
Recent SEC Filing | 08/17/2022![]() |
President, Chief Executive Officer & Director | Anthony S. Marucci |
CFO, Secretary, Treasurer & Senior Vice President | Sam Martin |
Chief Scientific Officer & Executive VP | Tibor Keler |
Chief Medical Officer & Senior Vice President | Diane C. Young |
Price Open | $36.64 |
Previous Close | $34.20 |
52 Week Range | $19.85 - 57.20 |
Market Capitalization | $1.6 B |
Shares Outstanding | 46.8 M |
Sector | Health Technology |
Industry | Medical Specialties | Next Earnings Announcement | 11/08/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$2.00 |
Beta vs. S&P 500 | N/A |
Revenue | $9.5 M |
Net Profit Margin | -12,093.93% |
Return on Equity | -24.62% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |